UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity

American journal of physiology. Heart and circulatory physiology, 2014-01, Vol.306 (1), p.H15-H25

Mathew, Rajamma

2014

Volltextzugriff (PDF)

Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension

Medical sciences (Basel), 2021-09, Vol.9 (4), p.58

Mathew, Rajamma

2021

Volltextzugriff (PDF)

Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension

Children (Basel), 2020-08, Vol.7 (8), p.100

Mathew, Rajamma

2020

Volltextzugriff (PDF)

Cell-Specific Dual Role of Caveolin-1 in Pulmonary Hypertension

Pulmonary Medicine, 2011-01, Vol.2011 (2011), p.175-186

2011

Volltextzugriff (PDF)

Metabolic Deregulation in Pulmonary Hypertension

Current issues in molecular biology, 2023-06, Vol.45 (6), p.4850-4874

2023

Volltextzugriff (PDF)

NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP‐C4‐2B prostate cancer model of progressive metastasis

The Prostate, 2018-11, Vol.78 (15), p.1181-1195

2018

Volltextzugriff (PDF)

Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats

Hypertension (Dallas, Tex. 1979), 2009-09, Vol.54 (3), p.668-675

2009

Volltextzugriff (PDF)

Pulmonary hypertension: current therapy and future prospects

Cardiovascular & hematological agents in medicinal chemistry, 2011-07, Vol.9 (3), p.165-182

Mathew, Rajamma

2011

Volltextzugriff (PDF)

Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1

World journal of cardiology, 2014-08, Vol.6 (8), p.692-705

Mathew, Rajamma

2014

Volltextzugriff (PDF)

Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways

Genes, 2020-01, Vol.11 (2), p.126

2020

Volltextzugriff (PDF)

Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature

Pulmonary circulation, 2019-01, Vol.9 (1), p.1-12

2019

Volltextzugriff (PDF)

Hematological disorders and pulmonary hypertension

World journal of cardiology, 2016-12, Vol.8 (12), p.703-718

2016

Volltextzugriff (PDF)

Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension

Experimental biology and medicine (Maywood, N.J.), 2010-07, Vol.235 (7), p.805-813

2010

Volltextzugriff (PDF)

Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction

American journal of physiology. Heart and circulatory physiology, 2009-04, Vol.296 (4), p.H1048-H1057

2009

Volltextzugriff (PDF)

Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension

American journal of physiology. Lung cellular and molecular physiology, 2008-06, Vol.294 (6), p.L1250-L1259

2008

Volltextzugriff (PDF)

Pulmonary Agenesis and Associated Pulmonary Hypertension: A Case Report and Review on Variability, Therapy, and Outcome

European journal of pediatric surgery reports, 2015-06, Vol.3 (1), p.033-039

2015

Volltextzugriff (PDF)

Loss of cavin1 and expression of p-caveolin-1 in pulmonary hypertension: Possible role in neointima formation

World journal of hypertension, 2019-05, Vol.9 (2), p.17-29

2019

Volltextzugriff (PDF)

Microvesicles and exosomes in pulmonary hypertension

Vessel Plus, 2020-05, Vol.2020

2020

Volltextzugriff (PDF)

PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal

Expert opinion on investigational drugs, 2012-02, Vol.21 (2), p.139-142

Mathew, Rajamma

2012

Volltextzugriff (PDF)

Inflammation and Pulmonary Hypertension

Cardiology in review, 2010-03, Vol.18 (2), p.67-72

Mathew, Rajamma

2010

Volltextzugriff (PDF)

Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation

World journal of cardiology, 2015-10, Vol.7 (10), p.671-684

2015

Volltextzugriff (PDF)

Associated inflammation or increased flow-mediated shear stress, but not pressure alone, disrupts endothelial caveolin-1 in infants with pulmonary hypertension

Pulmonary circulation, 2012-10, Vol.2 (4), p.492-500

2012

Volltextzugriff (PDF)

Gene therapy for pulmonary arterial hypertension: is a cure in sight?

Expert opinion on biological therapy, 2011-02, Vol.11 (2), p.129-131

Mathew, Rajamma

2011

Volltextzugriff (PDF)

G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease

Journal of the American Heart Association, 2024-10, Vol.13 (19), p.e035174

2024

Volltextzugriff (PDF)

Abstract B003: NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.B003-B003

2018

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity

Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension

Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension

Cell-Specific Dual Role of Caveolin-1 in Pulmonary Hypertension

Metabolic Deregulation in Pulmonary Hypertension

NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP‐C4‐2B prostate cancer model of progressive metastasis

Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats

Pulmonary hypertension: current therapy and future prospects

Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1

Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways

Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature

Hematological disorders and pulmonary hypertension

Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension

Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction

Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension

Pulmonary Agenesis and Associated Pulmonary Hypertension: A Case Report and Review on Variability, Therapy, and Outcome

Loss of cavin1 and expression of p-caveolin-1 in pulmonary hypertension: Possible role in neointima formation

Microvesicles and exosomes in pulmonary hypertension

PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal

Inflammation and Pulmonary Hypertension

Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation

Associated inflammation or increased flow-mediated shear stress, but not pressure alone, disrupts endothelial caveolin-1 in infants with pulmonary hypertension

Gene therapy for pulmonary arterial hypertension: is a cure in sight?

G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease

Abstract B003: NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis

Suchergebnisse filtern